SCHEMBL4458941

SCHEMBL4458941

C=CCOC(=O)NCCC

nearest known ligand 0.47

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
ACHE P22303 14/20 0.47
TSHR P16473 1/20 0.46
CHRNB2 P17787 1/20 0.45
CHRNB4 P30926 1/20 0.45
CHRNA3 P32297 1/20 0.45
CHRNA4 P43681 1/20 0.45
MEN1 O00255 2/20 0.44
KMT2A Q03164 2/20 0.44
L3MBTL1 Q9Y468 2/20 0.44
ALDH1A1 P00352 1/20 0.41
MAPT P10636 1/20 0.41
ATM Q13315 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8769203 0.89 ACHE (0.63) ACHETSHR
SCHEMBL13055388 0.87 MAPT (0.42) ACHETSHRMEN1KMT2AMAPT
SCHEMBL29940 0.87 ACHE (0.56) ACHETSHR
SCHEMBL14328774 0.85 EPHX1 (0.59) ACHETSHR
SCHEMBL8769159 0.85 EPHX1 (0.59) ACHETSHR
SCHEMBL8769636 0.85 EPHX1 (0.59) ACHETSHR
SCHEMBL6332791 0.85 EPHX1 (0.59) ACHETSHR
SCHEMBL6332081 0.85 EPHX1 (0.59) ACHETSHR
SCHEMBL8769221 0.85 EPHX1 (0.59) ACHETSHR
SCHEMBL10349440 0.85 EPHX1 (0.59) ACHETSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 73 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101065157-A Biomedical devices containing amphiphilic block copolymers JOHNSON & JOHNSON VISION CARE (US) 2007-10-31 CN claimed
CN-111936487-B Compounds for the treatment of kinase dependent disorders 埃克塞里艾克西斯公司 2024-07-09 CN disclosed
CN-112312909-B Compounds for the treatment of kinase dependent disorders 埃克塞里艾克西斯公司 2024-07-02 CN disclosed
CN-113710660-B DOT1L degradation agent and application thereof 达纳-法伯癌症研究公司 2024-07-02 CN disclosed
CN-117820226-A Compounds for the treatment of kinase dependent disorders 埃克塞里艾克西斯公司 2024-04-05 CN disclosed
CN-117751114-A Small molecule modulators of glucocerebrosidase activity and uses thereof 凡况生化公司 2024-03-22 CN disclosed
CN-117642404-A Small molecule modulators of glucocerebrosidase activity and uses thereof 凡况生化公司 2024-03-01 CN disclosed
CN-117624045-A Compounds for the treatment of kinase dependent disorders 埃克塞里艾克西斯公司 2024-03-01 CN disclosed
CN-117603138-A Compounds for the treatment of kinase dependent disorders 埃克塞里艾克西斯公司 2024-02-27 CN disclosed
CN-113896685-B Indoleamine-2, 3-dioxygenase (IDO) inhibitors 益方生物科技(上海)股份有限公司 2024-02-06 CN disclosed
CN-101065407-A Lactam polymer derivatives JOHNSON & JOHNSON VISION CARE (US) 2007-10-31 CN disclosed
CN-101065157-A Biomedical devices containing amphiphilic block copolymers JOHNSON & JOHNSON VISION CARE (US) 2007-10-31 CN disclosed
CN-101065686-A Wettable hydrogels containing reactive hydrophilic polymeric internal wetting agents JOHNSON & JOHNSON VISION CARE (US) 2007-10-31 CN disclosed
EP-1601723-A4 DILUENTS FOR FORMING CLEAR, WETTABLE SILICONE HYDROGEL ARTICLES JOHSON & JOHNSON VISION CARE I (US) 2007-06-20 EP disclosed
WO-2007047716-A2 SURFACE-MODIFIED MEDICAL DEVICES AND METHOD OF MAKING BAUSCH & LOMB INCORPORATED (US) 2007-04-26 WO disclosed
US-20070087113-A1 Surface-modified medical devices and method of making BAUSCH & LOMB INCORPORATED 2007-04-19 US disclosed
EP-1601723-A2 DILUENTS FOR FORMING CLEAR, WETTABLE SILICONE HYDROGEL ARTICLES J & J Vision Care, Inc. (US) 2005-12-07 EP disclosed
WO-2004081105-A2 DILUENTS FOR FORMING CLEAR, WETTABLE SILICONE HYDROGEL ARTICLES JONHSON AND JOHNSON VISION CARE, INC. (US) 2004-09-23 WO disclosed
US-4260552-A INSECTICIDES, HERBICIDES UNIROYAL, INC. (US) 1981-04-07 US disclosed
US-4160846-A Method for controlling insects with tetrasubstituted organotin compounds UNIROYAL, INC. (US) 1979-07-10 US disclosed